2024-09-24 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis Report

**Company Overview:** Abbott Laboratories is a global healthcare company that develops, manufactures, and markets a wide range of healthcare products.

**Performance Analysis:**

**1.  Return Rate Comparison:**

*   **ABT Cumulative Return:** 104.05%
*   **VOO (S&P 500) Cumulative Return:** 132.53%
*   **Return Difference:** -28.48% 
*   **Relative Divergence:** 13.9 (This means that ABT's performance is currently positioned at the 13.9th percentile of its historical performance range compared to the S&P 500.) 

**2. Recent Price Movements:**

*   **Closing Price:** $113.7
*   **5-day Moving Average:** $115.46
*   **20-day Moving Average:** $114.71
*   **60-day Moving Average:** $109.12

**3. Technical Indicators:**

*   **RSI:** 51.57 (Neutral)
*   **PPO:** -0.41 (Slightly bearish)
*   **Delta_Previous_Relative_Divergence:** -2.1 (Indicating a short-term downward trend)
*   **Expected Return:** 70.77% (Estimated 5-year expected return based on current investment amount)

**4. Recent Earnings and Outlook:**

| Date       | EPS | Revenue   |
| ---------- | --- | --------- |
| 2024-07-31 | 0.74 | 10.38 B$ |
| 2024-05-02 | 0.7  | 9.96 B$ |
| 2023-11-01 | 0.82 | 10.14 B$ |
| 2023-08-03 | 0.79 | 9.98 B$ |
| 2024-07-31 | 0.79 | 9.98 B$ |

The most recent earnings report (2024-07-31) shows an EPS of 0.74, exceeding analysts' expectations of 0.72. Revenue also beat estimates, coming in at $10.38 billion compared to the expected $10.31 billion. This indicates positive momentum in the company's financial performance.

**5. Overall Analysis:**

Abbott Laboratories is a mature company with a strong track record of delivering consistent financial performance. Although its recent returns have lagged behind the S&P 500, the company is currently demonstrating positive earnings and revenue growth. The technical indicators suggest a slight bearish bias in the short term, but the long-term outlook appears positive.

**6. Conclusion:**

ABT is a solid investment option for long-term investors seeking exposure to the healthcare sector. The company's consistent earnings growth, strong financial position, and robust dividend payouts make it an attractive choice. However, current market conditions and the technical indicators suggest potential for short-term volatility. Monitoring the stock price and earnings reports closely will be important in determining appropriate investment decisions. 
